Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 14, 2022

50715_rns_2022-07-14_6eb6bda9-1d8a-4204-b066-dba18f2d2a84.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

14 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Desof rsec criptionelevanturities Deof scriptionproducts Nature ofdealings Nurefesecwhi mber ofrenceurities toch the dcd Maturityate /losing outate Referenceprice Totalpaid amount/ received Reba(inth sultantlancecludingose of any
derivativesrelate person withwhom there isan agreementorunderstanding)
CICC FinancialTrading Limited 13 July2022 Derivatives Other types ofproducts Closing out of aderivative contract 42,000 15 July 2022 $21.4199 $899,634.7000 332,000

End

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.